THE EFFECTS OF G-33040 IN DEPRESSIVE STATES: A MULTI-BLIND STUDY
Abstract
From the data obtained from the present sample, the following conclusions may be drawn: 1) considering the rigorously controlled setting in which the drug was evaluated, Ensidon seems to be an adequately potent antidepressant substance reaching the statistical significance beyond 0.05 level; 2) the indication par excellence is that Ensidon seems to be effective in neurotic depressive states clinically and statistically and there is a relative lack of side effects and the sedative properties of this drug adds further to its suitability for ambulatory patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).